Core Operations: Production of APIs (e.g. paracetamol, ibuprofen, metformin), direct compression granules, intermediates, nutraceuticals, and finished formulation products Manufacturing: Five cGMP-approved plants across Telangana (Uppal, Nacharam, Shamshabad, Bollaram) and Solapur (Maharashtra), serving global markets including the US, EU, Canada, Australia, Latin America, and AsiaCertifications: US FDA, European EDMQ/EMA, ANVISA (Brazil), COFEPRIS (Mexico), MHRA (UK), TGA (Australia), Canadian Health Canada, ISO 9001, among others
Headquarters & Corporate Office: C‑4, Industrial Area, Uppal, Hyderabad, Telangana, India, PIN 500039 Manufacturing Units:
Unit I: Uppal, Hyderabad
Unit II: Nacharam, Hyderabad
Unit III: Golkonda Kalan, Shamshabad
Unit IV: Bollaram, Medak District
Unit V: MIDC, Chincholi, Solapur, Maharashtra